141 related articles for article (PubMed ID: 27455475)
1. Effective method of measuring the radioactivity of [ 131I]-capsule prior to radioiodine therapy with significant reduction of the radiation exposure to the medical staff.
Lützen U; Zhao Y; Marx M; Imme T; Assam I; Siebert FA; Culman J; Zuhayra M
J Appl Clin Med Phys; 2016 Jul; 17(4):59-72. PubMed ID: 27455475
[TBL] [Abstract][Full Text] [Related]
2. A simple, reliable and accurate approach for assessing [
Zuhayra M; Helm A; Ranjan J; Jüptner M; Zhao Y; Marx M; Assam I; Alfteimi A; Lützen U
Phys Med; 2022 Apr; 96():157-165. PubMed ID: 35306454
[TBL] [Abstract][Full Text] [Related]
3. Determination of Radiation Exposure of Individuals in the Population by Patients after Radioiodine Therapy - Comparison of two Measurement Systems.
Hartmann H; Andreeff M; Claußnitzer J; Kotzerke J; Brogsitter C
Rofo; 2023 Jul; 195(7):605-612. PubMed ID: 37160149
[TBL] [Abstract][Full Text] [Related]
4. Assessment of exposure of workers to ionizing radiation from radioiodine and technetium in nuclear medicine departmental facilities.
Krajewska G; Pachocki KA
Med Pr; 2013; 64(5):625-30. PubMed ID: 24502125
[TBL] [Abstract][Full Text] [Related]
5. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
Wellner U; Eschner W; Hillger HW; Schicha H
Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232
[TBL] [Abstract][Full Text] [Related]
6. Estimation of patient attenuation factor for iodine-131 based on direct dose rate measurements from radioiodine therapy patients.
Soliman K; Alenezi A
Nucl Med Commun; 2015 Feb; 36(2):125-8. PubMed ID: 25279710
[TBL] [Abstract][Full Text] [Related]
7. Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I.
Rini JN; Vallabhajosula S; Zanzonico P; Hurley JR; Becker DV; Goldsmith SJ
Thyroid; 1999 Apr; 9(4):347-52. PubMed ID: 10319939
[TBL] [Abstract][Full Text] [Related]
8. Internal exposure monitoring of 131I-radiopharmaceutical production workers in Iran.
Alirezazadeh N; Garshasbi H; Karimi Diba J
Radiat Prot Dosimetry; 2003; 104(2):173-6. PubMed ID: 12918795
[TBL] [Abstract][Full Text] [Related]
9. Is it safe to work with iodine-131 if you are pregnant? A risk assessment for nuclear medicine staff involved with cleaning and decontamination.
Barber RW; Parkin A; Goldstone KE
Nucl Med Commun; 2003 May; 24(5):571-4. PubMed ID: 12717076
[TBL] [Abstract][Full Text] [Related]
10. Internal Dose Assessment after 131I-Iodide Misadministration in a Patient With Incompletely Blocked Thyroid Uptake: Personalized Internal Dose Assessment by Estimating Individual-Specific Biokinetics.
Kwon TE; Park M; Kang JK; Cho M; Jang S; Kim KM; Ha WH; Jin YW
Health Phys; 2019 Jun; 116(6):760-770. PubMed ID: 30920994
[TBL] [Abstract][Full Text] [Related]
11. Radiation protection issues of treating hyperthyroidism with 131 I in patients on haemodialysis.
Homer L; Smith AH
Nucl Med Commun; 2002 Mar; 23(3):261-4. PubMed ID: 11891485
[TBL] [Abstract][Full Text] [Related]
12. 131I exhalation by patients undergoing therapy of thyroid diseases.
Gründel M; Kopka B; Schulz R
Radiat Prot Dosimetry; 2008; 129(4):435-8. PubMed ID: 17993652
[TBL] [Abstract][Full Text] [Related]
13. Uncertainties in dose coefficients from ingestion of 131I, 137Cs, and 90Sr.
Apostoaei AI; Miller LF
Health Phys; 2004 May; 86(5):460-82. PubMed ID: 15083142
[TBL] [Abstract][Full Text] [Related]
14. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
Marcus CS; Siegel JA
J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
[No Abstract] [Full Text] [Related]
15. [Measurement of ocular lens ionizing radiation exposure after radioiodine therapy].
Andreeff M; Claussnitzer J; Oehme L; Freudenberg R; Kotzerke J
Nuklearmedizin; 2012; 51(3):79-83. PubMed ID: 22395665
[TBL] [Abstract][Full Text] [Related]
16. RADIATION PROTECTION IN THE RELEASE OF PATIENTS RECEIVING 131I TREATMENT.
Mattar E; Salih MA; Alsafi K; Suliman II
Radiat Prot Dosimetry; 2019 Dec; 187(4):499-508. PubMed ID: 31605121
[TBL] [Abstract][Full Text] [Related]
17. Measurement and analysis of patient attenuation correction factor during radioiodine therapy.
Soliman K; Alenezi A; Bakkari M; Shirbini H
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):448-51. PubMed ID: 25862533
[TBL] [Abstract][Full Text] [Related]
18. A practical individualized radiation precaution based on the dose rate at release time after inpatient 131I ablation therapy.
Han S; Jin S; Yoo SH; Lee HS; Lee SH; Jeon MJ; Ryu JS
PLoS One; 2021; 16(5):e0251627. PubMed ID: 34019555
[TBL] [Abstract][Full Text] [Related]
19. Calculation of Blood Dose in Patients Treated With 131I Using MIRD, Imaging, and Blood Sampling Methods.
Piruzan E; Haghighatafshar M; Faghihi R; Entezarmahdi SM
Medicine (Baltimore); 2016 Mar; 95(11):e3154. PubMed ID: 26986171
[TBL] [Abstract][Full Text] [Related]
20. Nuclear medicine staff exposure to ionising radiation in
Pavičar B; Davidović J; Petrović B; Vuleta G; Trivić S; Šajinović V; Egeljić-Mihailović N; Todorović N; Predojević B
Arh Hig Rada Toksikol; 2021 Sep; 72(3):216-224. PubMed ID: 34587667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
